Related Experiment Video
Updated: Jul 2, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Mechanisms of sepsis and insights from clinical trials
Nitin Seam1, Anthony F Suffredini
1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Abstract:
Multiple clinical trials of adjunctive therapy for sepsis and septic shock have been conducted to neutralize bacterial components or to modulate host inflammatory responses to infection but with limited success. Many therapies are only beneficial only in patients with a high severity of illness and have minimal or harmful effects in patients that are less severely ill. Improved measures of severity of illness and discovery of biomarkers to help identify these high-risk patients are needed.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Acute Inflammation III: Local and Systemic Effects
Determinants of Bacterial Pathogenicity and Virulence
Bacterial Meningitis II: Pathophysiology
Clinical Trials: Overview
Pneumonia II: Pathophysiology

